Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | ARGX | ALNY | ||
| Company | Csl Ltd ADR | Argenx Se ADR | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 24.8030 | 847.20 | 306.56 | ||
| High | 24.8100 | 847.20 | 312.25 | ||
| Low | 23.6200 | 831.43 | 305.00 | ||
| Latest | 24.7500 | 834.45 | 310.94 | ||
| Change | -0.0400 | -14.59 | +1.28 | ||
| % Change | -0.16% | -1.72% | +0.41% | ||
| Volume | 435,100 | 217,700 | 966,500 | ||
| 20-Day Average Volume | 677,400 | 316,485 | 1,098,870 | ||
| Previous Close | 24.7900 | 849.04 | 309.66 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.6283 | 762.70 | 322.52 | ||
| 20-Day Raw Stochastic | 58.87% | 90.39% | 25.88% | ||
| 20-Day Relative Strength | 45.44 | 62.78 | 43.72 | ||
| Weighted Alpha | -38.49 | +34.23 | +1.67 | ||
| Today's Opinion | 88% Sell | 8% Buy | 96% Sell | ||
| Previous Opinion | 88% Sell | 8% Buy | 96% Sell | ||
| Last Month's Opinion | 100% Sell | 72% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.57% since 04/13/26 | +3.11% since 04/13/26 | -6.62% since 04/13/26 | ||
| Low | 23.6200 on 04/20/26 | 814.50 on 04/14/26 | 305.00 on 04/20/26 | ||
| High | 25.8400 on 04/15/26 | 852.28 on 04/17/26 | 343.36 on 04/14/26 | ||
| 1-Month | |||||
| %Chg | +3.30% since 03/20/26 | +25.68% since 03/20/26 | -0.39% since 03/20/26 | ||
| Low | 23.1900 on 03/31/26 | 666.79 on 03/24/26 | 299.62 on 03/24/26 | ||
| High | 25.8400 on 04/15/26 | 852.28 on 04/17/26 | 343.36 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | -16.54% since 01/20/26 | +3.06% since 01/20/26 | -12.54% since 01/20/26 | ||
| Low | 22.8300 on 03/19/26 | 661.85 on 03/20/26 | 298.00 on 02/12/26 | ||
| High | 33.5316 on 02/10/26 | 881.89 on 01/27/26 | 376.87 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | -30.64% since 10/20/25 | -1.77% since 10/20/25 | -36.70% since 10/20/25 | ||
| Low | 22.8300 on 03/19/26 | 661.85 on 03/20/26 | 298.00 on 02/12/26 | ||
| High | 36.2850 on 10/22/25 | 934.62 on 12/03/25 | 490.05 on 10/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 48,124,236 | 52,800,088 | 41,317,312 | ||
| Shares Outstanding, K | 1,941,276 | 62,188 | 133,428 | ||
| Annual Sales | 15,558,000,000 | 4,248,050,000 | 3,713,940,000 | ||
| Annual Net Income | 3,002,000,000 | 1,292,040,000 | 313,750,000 | ||
| Last Quarter Sales | N/A | 1,322,160,000 | 1,097,030,000 | ||
| Last Quarter Net Income | N/A | 532,950,000 | 186,420,000 | ||
| 60-Month Beta | 0.80 | 0.46 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 8.02 on 02/26/26 | 1.25 on 02/12/26 | ||
| Latest Earnings Date | 08/19/25 | 05/14/26 | 04/30/26 | ||
| Most Recent Dividend | 0.294 on 03/11/26 | N/A | N/A | ||
| Next Ex-Dividends Date | 03/11/26 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 42.44 | 188.31 | ||